Clinicopathological features and survival outcomes of primary signet ring cell and mucinous adenocarcinoma of colon: Retrospective analysis of VACCR database

Journal of Gastrointestinal Oncology

Volumn 5, Issue 1, 2014, Pages 18-24

  Thota, Ramya ^a   Fang, Xiang ^b   Subbiah, Shanmuga ^c  

^a VANDERBILT UNIVERSITY   (United States)

^b CREIGHTON UNIVERSITY   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Colon; Mucinous and non mucinous adenocarcinoma; Signet ring cell carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; AGE; AGED; APPENDIX CARCINOMA; ARTICLE; ASCENDING COLON; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER LOCALIZATION; CANCER PATIENT; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CAUCASIAN; CECUM CARCINOMA; CLINICAL FEATURE; COLON ADENOCARCINOMA; COLON MUCINOUS ADENOCARCINOMA; COLON SURGERY; CONTROLLED STUDY; DATA BASE; DESCENDING COLON; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NEGRO; OUTCOME ASSESSMENT; PRIMARY TUMOR; RETROSPECTIVE STUDY; SIGMOID CARCINOMA; SIGNET RING CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TRANSVERSE COLON;

EID: 84995777871     PISSN: 20786891     EISSN: 2219679X     Source Type: Journal    
DOI: 10.3978/j.issn.2078-6891.2013.051     Document Type: Article

References (21)

1. Almagro UA. Primary signet-ring carcinoma of the colon. Cancer 1983;52:1453-7.
2. Tung SY, Wu CS, Chen PC. Primary signet ring cell carcinoma of colorectum: an age- and sex-matched controlled study. Am J Gastroenterol 1996;91:2195-9.
3. Hamilton SR, Rubio CA, Vogelstein B, et al. Carcinoma of the colon and rectum. In: Hamilton SR, Aaltonen LA. eds. World Health Organization classification of tumours. Tumours of the digestive system. Lyon, France: IARC Press, 2000:101-19.
4. Kang H, O'Connell JB, Maggard MA, et al. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum 2005;48:1161-8.
5. Sasaki S, Masaki T, Umetani N, et al. Characteristics in primary signet-ring cell carcinoma of the colorectum, from clinicopathological observations. Jpn J Clin Oncol 1998;28:202-6.
6. Anthony T, George R, Rodriguez-Bigas M, et al. Primary signet-ring cell carcinoma of the colon and rectum. Ann Surg Oncol 1996;3:344-8.
7. Sung CO, Seo JW, Kim KM, et al. Clinical significance of signet-ring cells in colorectal mucinous adenocarcinoma. Mod Pathol 2008;21:1533-41.
8. Lee WS, Chun HK, Lee WY, et al. Treatment outcomes in patients with signet ring cell carcinoma of the colorectum. Am J Surg 2007;194:294-8.
9. Du W, Mah JT, Lee J, Sankila R, et al. Incidence and survival of mucinous adenocarcinoma of the colorectum: a population-based study from an Asian country. Dis Colon Rectum 2004;47:78-85.
10. Wu CS, Tung SY, Chen PC, et al. Clinicopathological study of colorectal mucinous carcinoma in Taiwan: a multivariate analysis. J Gastroenterol Hepatol 1996;11:77-81.
11. Symonds DA, Vickery AL. Mucinous carcinoma of the colon and rectum. Cancer 1976;37:1891-900.
12. Ponz de Leon M, Di Gregorio C. Pathology of colorectal cancer. Dig Liver Dis 2001;33:372-88.
13. Imperiale TF, RansohoffDF, Itzkowitz SH, et al. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004;351:2704-14.
14. Kakar S, Smyrk TC. Signet ring cell carcinoma of the colorectum: correlations between microsatellite instability, clinicopathologic features and survival. Mod Pathol 2005;18:244-9.
15. Gryfe R, Kim H, Hsieh ET, et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 2000;342:69-77.
16. Song GA, Deng G, Bell I, et al. Mucinous carcinomas of the colorectum have distinct molecular genetic characteristics. Int J Oncol 2005;26:745-50.
17. Ogino S, Brahmandam M, Cantor M, et al. Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component. Mod Pathol 2006;19:59-68.
18. Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature 2002;417:949-54.
19. Safaee Ardekani G, Jafarnejad SM, Tan L, et al. The prognostic value of BRAF mutation in colorectal cancer and melanoma: a systematic review and meta-analysis. PLoS One 2012;7:e47054.
20. Sentani K, Oue N, Tashiro T, et al. Immunohistochemical staining of Reg IV and claudin-18 is useful in the diagnosis of gastrointestinal signet ring cell carcinoma. Am J Surg Pathol 2008;32:1182-9.
21. Park SY, Lee HS, Choe G, et al. Clinicopathological characteristics, microsatellite instability, and expression of mucin core proteins and p53 in colorectal mucinous adenocarcinomas in relation to location. Virchows Arch 2006;449:40-7.